Springfeld C, Ferrone CR, Katz MHG, Philip PA, Hong TS, Hackert T et al. Neoadjuvant therapy for pancreatic cancer. Nat. Rev. Clin. Oncol. 2023;20:318–337.

Halbrook CJ, Lyssiotis CA, Pasca di Magliano M, Maitra A. Pancreatic cancer: advances and challenges. Cell. 2023;186:1729–54.

Article  CAS  PubMed  Google Scholar 

Cruciat CM, Dolde C, de Groot RE, Ohkawara B, Reinhard C, Korswagen HC, et al. RNA helicase DDX3 is a regulatory subunit of casein kinase 1 in Wnt-β-catenin signaling. Science. 2013;339:1436–41.

Article  ADS  CAS  PubMed  Google Scholar 

Chen CY, Chan CH, Chen CM, Tsai YS, Tsai TY, Wu Lee YH, et al. Targeted inactivation of murine Ddx3x: essential roles of Ddx3x in placentation and embryogenesis. Hum Mol Genet. 2016;25:2905–22.

CAS  PubMed  Google Scholar 

Song H, Ji X. The mechanism of RNA duplex recognition and unwinding by DEAD-box helicase DDX3X. Nat Commun. 2019;10:3085.

Article  ADS  PubMed  PubMed Central  Google Scholar 

Samir P, Kesavardhana S, Patmore DM, Gingras S, Malireddi RKS, Karki R, et al. DDX3X acts as a live-or-die checkpoint in stressed cells by regulating NLRP3 inflammasome. Nature. 2019;573:590–4.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Mo J, Liang H, Su C, Li P, Chen J, Zhang B. DDX3X: structure, physiologic functions and cancer. Mol Cancer. 2021;20:38.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liang S, Yang Z, Li D, Miao X, Yang L, Zou Q, et al. The clinical and pathological significance of nectin-2 and DDX3 expression in pancreatic ductal adenocarcinomas. Dis Markers. 2015;2015:379568.

Article  PubMed  PubMed Central  Google Scholar 

Zheng Y, Xu B, Zhao Y, Yang S, Wang S, Ma L, et al. DEAD-box helicase 3 X-linked promotes metastasis by inducing epithelial-mesenchymal transition via p62/sequestosome-1. Dig Dis Sci. 2021;66:3893–902.

Article  CAS  PubMed  Google Scholar 

Chen B, Zang W, Wang J, Huang Y, He Y, Yan L, et al. The chemical biology of sirtuins. Chem Soc Rev. 2015;44:5246–64.

Article  CAS  PubMed  Google Scholar 

Houtkooper RH, Pirinen E, Auwerx J. Sirtuins as regulators of metabolism and healthspan. Nat Rev Mol Cell Biol. 2012;13:225–38.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu QJ, Zhang TN, Chen HH, Yu XF, Lv JL, Liu YY, et al. The sirtuin family in health and disease. Signal Transduct Target Ther. 2022;7:402.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim JK, Noh JH, Jung KH, Eun JW, Bae HJ, Kim MG, et al. Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b. Hepatology. 2013;57:1055–67.

Article  CAS  PubMed  Google Scholar 

Yi X, Wang H, Yang Y, Wang H, Zhang H, Guo S, et al. SIRT7 orchestrates melanoma progression by simultaneously promoting cell survival and immune evasion via UPR activation. Signal Transduct Target Ther. 2023;8:107.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu F, Xu L, Tu Y, Cheung OK, Szeto LL, Mok MT, et al. Sirtuin 7 super-enhancer drives epigenomic reprogramming in hepatocarcinogenesis. Cancer Lett. 2022;525:115–30.

Article  CAS  PubMed  Google Scholar 

He X, Li Y, Chen Q, Zheng L, Lou J, Lin C, et al. O-GlcNAcylation and stablization of SIRT7 promote pancreatic cancer progression by blocking the SIRT7-REGγ interaction. Cell Death Differ. 2022;29:1970–81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Blank MF, Chen S, Poetz F, Schnölzer M, Voit R, Grummt I. SIRT7-dependent deacetylation of CDK9 activates RNA polymerase II transcription. Nucleic Acids Res. 2017;45:2675–86.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee N, Kim DK, Kim ES, Park SJ, Kwon JH, Shin J, et al. Comparative interactomes of SIRT6 and SIRT7: implication of functional links to aging. Proteomics. 2014;14:1610–22.

Article  CAS  PubMed  Google Scholar 

Lin TC. DDX3X is epigenetically repressed in renal cell carcinoma and serves as a prognostic indicator and therapeutic target in cancer progression. Int J Mol Sci. 2020;21:2881.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Z, Zhou Y, Jia Y, Wang C, Zhang M, Xu Z. PRR34-AS1 promotes exosome secretion of VEGF and TGF-β via recruiting DDX3X to stabilize Rab27a mRNA in hepatocellular carcinoma. J Transl Med. 2022;20:491.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xie M, Vesuna F, Tantravedi S, Bol GM, Heerma van Voss MR, Nugent K, et al. RK-33 radiosensitizes prostate cancer cells by blocking the RNA helicase DDX3. Cancer Res. 2016;76:6340–50.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bol GM, Vesuna F, Xie M, Zeng J, Aziz K, Gandhi N, et al. Targeting DDX3 with a small molecule inhibitor for lung cancer therapy. EMBO Mol Med. 2015;7:648–69.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shen L, Zhang J, Xu M, Zheng Y, Wang M, Yang S, et al. DDX3 acts as a tumor suppressor in colorectal cancer as loss of DDX3 in advanced cancer promotes tumor progression by activating the MAPK pathway. Int J Biol Sci. 2022;18:3918–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bol GM, Xie M, Raman V. DDX3, a potential target for cancer treatment. Mol Cancer. 2015;14:188.

Article  PubMed  PubMed Central  Google Scholar 

Fu R, Yang P, Li Z, Liu W, Amin S, Li Z. Avenanthramide A triggers potent ROS-mediated anti-tumor effects in colorectal cancer by directly targeting DDX3. Cell Death Dis. 2019;10:593.

Article  PubMed  PubMed Central  Google Scholar 

Karmakar S, Rauth S, Nallasamy P, Perumal N, Nimmakayala RK, Leon F, et al. RNA polymerase II-associated factor 1 regulates stem cell features of pancreatic cancer cells, independently of the PAF1 complex, via interactions with PHF5A and DDX3. Gastroenterology. 2020;159:1898–1915.e1896.

Article  CAS  PubMed  Google Scholar 

Hao L, Zhang Q, Qiao HY, Zhao FY, Jiang JY, Huyan LY, et al. TRIM29 alters bioenergetics of pancreatic cancer cells via cooperation of miR-2355-3p and DDX3X recruitment to AK4 transcript. Mol Ther Nucleic Acids. 2021;24:579–90.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang X, Kuang W, Ding J, Li J, Ji M, Chen W, et al. Systematic identification of the RNA-binding protein STAU2 as a key regulator of pancreatic adenocarcinoma. Cancers (Basel). 2022;14:3629.

Article  CAS  PubMed  Google Scholar 

Grootaert MOJ, Bennett MR. Sirtuins in atherosclerosis: guardians of healthspan and therapeutic targets. Nat Rev Cardiol. 2022;19:668–83.

Article  CAS  PubMed  Google Scholar 

Onyiba CI, Scarlett CJ, Weidenhofer J. The mechanistic roles of sirtuins in breast and prostate cancer. Cancers (Basel). 2022;14:5118.

Article  CAS  PubMed  Google Scholar 

Aventaggiato M, Vernucci E, Barreca F, Russo MA, Tafani M. Sirtuins’ control of autophagy and mitophagy in cancer. Pharmacol Ther. 2021;221:107748.

Article  CAS  PubMed  Google Scholar 

Zhu S, Dong Z, Ke X, Hou J, Zhao E, Zhang K, et al. The roles of sirtuins family in cell metabolism during tumor development. Semin Cancer Biol. 2019;57:59–71.

Article  CAS  PubMed  Google Scholar 

Lagunas-Rangel FA. SIRT7 in the aging process. Cell Mol Life Sci. 2022;79:297.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huo Q, Chen S, Zhuang J, Quan C, Wang Y, Xie N. SIRT7 downregulation promotes breast cancer metastasis via LAP2α-induced chromosomal instability. Int J Biol Sci. 2023;19:1528–42.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang C, Zhao J, Zhao J, Liu B, Tang W, Liu Y, et al. CYP2E1-dependent upregulation of SIRT7 is response to alcohol mediated metastasis in hepatocellular carcinoma. Cancer Gene Ther. 2022;29:1961–74.

Article  CAS  PubMed  PubMed Central